CoreComm Internet

Features

Make this your home page

RFK Jr. eases access to unproven peptides despite opposition from FDA scientists

WASHINGTON (AP) — The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. Food and Drug Administration scientific staffers had little input on the decision and opposed the changes, according to six people familiar with its development. The draft policy posted online by Kennedy’s Department of Health and Human Services covers a handful of injectable peptides promoted within the wellness industry for uses such as...

Read More
 

----------
Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

CoreComm is not responsible for content on external sites. Please review the privacy and security policies of each vendor before making online purchases or providing personal information. Forecast Information Provided by AccuWeather.